Skip to main content
Smart Investors Daily
SM

OTC · SMMNY

Siemens Healthineers AG

Healthcare · Medical - Devices

$23.81

Down-$0.16 (-0.67%)

Updated Oct 31, 2026, 6:21 PM

SID Score

6.1/10

Composite research score

Smart Money

46/100

Neutral

Market cap
114.27B
P/E ratio
22.9
Dividend yield
2.09%
52-week range
$19.20 – $28.92
Volume
49.38K
Avg. volume
119.49K

Price performance · SMMNY

SMMNY price history

1M range · 5 trading sessions · Daily adjusted prices

Prices through Oct 8, 2026

SMMNY closed at $21.64 after 5 trading sessions, up 1.63% for the selected period.

Last close
$21.64
Period change
+1.63%
Period low
$21.08
Period high
$21.64
Daily close
View OHLC price history
SMMNY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 8, 2026$21.47$21.64$21.385$21.63649.38K
Oct 7, 2026$21.45$21.58$21.366$21.5240.94K
Oct 6, 2026$21.66$21.66$21.29$21.3366.59K
Oct 5, 2026$20.80$21.09$20.79$21.0892.09K
Oct 2, 2026$21.37$21.37$21.22$21.2966.81K

Latest SMMNY news

The latest Smart Investors Daily articles mentioning SMMNY.

SMMNY research

Overview

Company profile and research snapshot.

Company profile

SIEMENS HEALTHINEERS ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
14
SMMNY recent ratings
DateFirmRatingTarget
Sep 21, 2026BERENBERGHold—
Sep 7, 2026JEFFERIESBuy—
Aug 28, 2026METZLER EQUITIESHold—
Aug 24, 2026HSBC GLOBAL INVESTMENT RESEARCHBuy—
Aug 7, 2026EQUITA SIMHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 30, 2026

Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth

New distribution agreement positions TULSA-PRO within the iMRI Suite offering through Cook Medical’s Copernicus™ program, expanding Profound’s commercial reach Profound retains direct TULSA-PRO recurring treatment kit and service revenue relationships for systems sold through Cook Medical Agreement complements Profound’s existing Siemens Healthineers relationship and broader strategy to expand access to MRI-guided regional prostate ablation TORONTO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Profound Med

Yahoo · Oct 26, 2026

Xunce TokenOS Expands Deep into Germany, the Heart of Europe, Marking Further Progress in Its Internationalization Layout

HONG KONG, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Recently, Berlin Global Dialogue (BGD) 2026 and the Invest in Germany Summit were held concurrently in Berlin, Germany. Xunce (3317.HK) was invited to attend as a strategic partner. The company’s management and representatives participated in relevant events and held in-depth exchanges with stakeholders from all sectors on topics including AI data infrastructure and China-Europe data cooperation. Seizing this opportunity, the company’s new-generation

Yahoo · Oct 23, 2026

Global Computed Tomography (CT) Market by Application, Technology, Care Setting, and Product: Five-Year Forecast | Photon-Counting Scanners and AI Breathe New Life Into a Mature CT Market

Mobile imaging, photon-counting technology and AI integration are reshaping the computed tomography market despite market maturity and coverage hurdles, a new 192-page Research and Markets report finds; GE Healthcare, Siemens Healthineers, Philips and Canon Medical Systems are among 14 companies profiled.Dublin, Oct. 23, 2026 (GLOBE NEWSWIRE) -- "Computed Tomography (CT) Market By Application, By Technology, By Place and By Product with Executive and Consultant Guides" has been added to Research

Yahoo · Oct 23, 2026

Global Breast Cancer Screening and Diagnostics Market, 2026-2036 | AI Imaging and Wider Screening Push Breast-Cancer Diagnostics Toward $12 Billion

The global breast cancer screening and diagnostics market is projected to roughly double from $5.9 billion in 2026 to $12.15 billion by 2036, a new Research and Markets report finds, as GE HealthCare, Hologic and Siemens Healthineers roll out new imaging and AI tools despite high equipment costs.Dublin, Oct. 23, 2026 (GLOBE NEWSWIRE) -- "Breast Cancer Screening and Diagnostics Market - A Global and Regional Analysis: Focus on Product, Application, End User, Regional, and Country-Level Analysis -

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.